Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

swedish orphan biovitrum ab - SWOBY

SWOBY

Close Chg Chg %
15.22 1.98 13.01%

Pre-Market

17.20

+1.98 (13.01%)

Volume: 122.00

Last Updated:

Nov 14, 2024, 11:52 AM EDT

Trade Now

Company Overview: swedish orphan biovitrum ab - SWOBY

SWOBY Key Data

Open

$17.20

 Day Range

17.20 - 17.20

52 Week Range

10.88 - 17.20

 Market Cap

$9.77B

Shares Outstanding

686.87M

 Public Float

N/A

Beta

1.71

 Rev. Per Employee

N/A

P/E Ratio

29.01

 EPS

$0.49

Yield

0.00%

 Dividend

$0.45

EX-DIVIDEND DATE

Sep 21, 2023

 SHORT INTEREST

N/A

AVERAGE VOLUME

432.87

  

SWOBY Performance

1 Week
 
 0.00%
 
1 Month
 
 5.68%
 
3 Months
 
 26.66%
 
1 Year
 
 N/A
 
5 Years
 
 N/A
 

SWOBY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔
An error occurred while fetching the data.
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Swedish Orphan Biovitrum Ab - SWOBY

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
1.66B 1.81B 1.86B 2.08B
Sales Growth
+10.09% +9.11% +2.64% +12.24%
Cost of Goods Sold (COGS) incl D&A
566.23M 634.74M 644.67M 760.27M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
219.78M 232.86M 224.61M 298.51M
Depreciation
15.32M 18.40M 15.32M 17.14M
Amortization of Intangibles
204.46M 214.45M 209.29M 281.37M
COGS Growth
+11.76% +12.10% +1.57% +17.93%
Gross Income
1.09B 1.17B 1.21B 1.32B
Gross Income Growth
+9.24% +7.55% +3.23% +9.22%
Gross Profit Margin
+65.85% +64.91% +65.28% +63.52%
2020 2021 2022 2023 5-year trend
SG&A Expense
607.08M 735.61M 764.63M 885.18M
Research & Development
171.76M 229.94M 219.27M 256.12M
Other SG&A
435.32M 505.67M 545.36M 629.05M
SGA Growth
+23.70% +21.17% +3.94% +15.77%
Other Operating Expense
- - - -
-
Unusual Expense
(43.35M) 815.41K 70.65M 45.59M
EBIT after Unusual Expense
527.99M 437.76M 376.78M 392.99M
Non Operating Income/Expense
(16.95M) (5.13M) (3.26M) (10.08M)
Non-Operating Interest Income
- 108.64K 494.08K 2.54M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
52.91M 48.81M 45.36M 104.65M
Interest Expense Growth
+92.51% -7.75% -7.07% +130.74%
Gross Interest Expense
52.91M 48.81M 45.36M 104.65M
Interest Capitalized
- - - -
-
Pretax Income
458.13M 383.82M 328.17M 278.26M
Pretax Income Growth
+2.05% -16.22% -14.50% -15.21%
Pretax Margin
+27.63% +21.22% +17.67% +13.35%
Income Tax
105.60M 71.76M 67.49M 51.34M
Income Tax - Current - Domestic
122.22M 76.76M 62.06M 36.55M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(16.62M) (5.01M) 5.43M 14.79M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
352.54M 312.07M 260.67M 226.92M
Minority Interest Expense
- - - -
-
Net Income
352.54M 312.07M 260.67M 226.92M
Net Income Growth
+0.94% -11.48% -16.47% -12.95%
Net Margin Growth
+21.26% +17.25% +14.04% +10.89%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
352.54M 312.07M 260.67M 226.92M
Preferred Dividends
- - - -
-
Net Income Available to Common
352.54M 312.07M 260.67M 226.92M
EPS (Basic)
0.5714 0.5051 0.4212 0.3516
EPS (Basic) Growth
+0.26% -11.60% -16.61% -16.52%
Basic Shares Outstanding
616.97M 617.80M 618.96M 645.32M
EPS (Diluted)
0.5657 0.5022 0.4171 0.3481
EPS (Diluted) Growth
-0.11% -11.23% -16.95% -16.54%
Diluted Shares Outstanding
623.22M 621.46M 624.91M 651.94M
EBITDA
704.42M 671.43M 672.04M 737.10M
EBITDA Growth
+5.45% -4.68% +0.09% +9.68%
EBITDA Margin
+42.49% +37.12% +36.19% +35.37%

Swedish Orphan Biovitrum Ab in the News